Summary
The response of tumor intracellular pH to a pharmacological challenge could help identify aggressive cancer. Chemical exchange saturation transfer (CEST) is an MRI contrast mechanism that is dependent on intracellular pH (pHi). pHi is important in the maintenance of normal cell function and is normally maintained within a narrow range by the activity of transporters located at the plasma membrane. In cancer, changes in pHi have been correlated with both cell proliferation and cell death. Quercetin is a bioflavonoid and monocarboxylate transporter (MCT) inhibitor. Since MCTs plays a significant role in maintaining pH balance in the tumor microenvironment, we hypothesized that systemically administered quercetin could selectively acidify brain tumors. The goals of the current study were to determine whether CEST MRI measurements sensitive to tumor pH could detect acidification after quercetin injection and to measure the magnitude of the pH change (ΔpH). Using a 9.4 T MRI, amine and amide concentration independent detection (AACID) CEST spectra were acquired in six mice approximately 15 ± 1 days after implanting 105 U87 human glioblastoma multiforme cells in the brain, before and after administration of quercetin (dose: 200 mg/kg) by intraperitoneal injection. Three additional mice were studied as controls and received only vehicle dimethyl sulfoxide (DMSO) injection. Repeated measures t-test was used to compare AACID changes in tumor and contralateral tissue regions of interest. Two hours after quercetin injection there was a significant increase in tumor AACID by 0.07 ± 0.03 corresponding to a 0.27 decrease in pHi, and no change in AACID in contralateral tissue. There was also a small average increase in AACID in tumors within the three mice injected with DMSO only. The use of the natural compound quercetin in combination with pH weighted MRI represents a unique approach to cancer detection that does not require injection of an imaging contrast agent.
This is a preview of subscription content,
to check access.



Abbreviations
- GBM:
-
glioblastoma multiforme
- pHi :
-
intracellular pH
- pHe :
-
extracellular pH
- PBS:
-
phosphate buffered saline
- CEST:
-
chemical exchange saturation transfer
- MCT:
-
monocarboxylate transporter
- DMSO:
-
Dimethyl sulfoxide
- RF:
-
radiofrequency
- MTRasym :
-
asymmetric magnetization transfer ratio
- MT:
-
magnetization transfer
- AACID:
-
amine and amide concentration-independent detection
- FSE:
-
fast spin-echo
- WASSR:
-
water saturation shift referencing
- ROI:
-
region of interest
References
Kanu OO, Mehta A, Di C, Lin N, Bortoff K, Bigner DD, Yan H, Adamson DC (2009) Glioblastoma multiforme: a review of therapeutic targets. Expert Opin Ther Targets 13(6):701–718. https://doi.org/10.1517/14728220902942348
Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507. https://doi.org/10.1056/NEJMra0708126
Sagiyama K, Mashimo T, Togao O, Vemireddy V, Hatanpaa KJ, Maher EA, Mickey BE, Pan E, Sherry AD, Bachoo RM, Takahashi M (2014) In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proc Natl Acad Sci U S A 111(12):4542–4547. https://doi.org/10.1073/pnas.1323855111
Easaw JC, Mason WP, Perry J, Laperriere N, Eisenstat DD, Del Maestro R, Belanger K, Fulton D, Macdonald D, Canadian Glioblastoma Recommendations C (2011) Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme. Curr Oncol 18(3):e126–e136
Gerweck LE, Seetharaman K (1996) Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 56(6):1194–1198
Stubbs M, Bhujwalla ZM, Tozer GM, Rodrigues LM, Maxwell RJ, Morgan R, Howe FA, Griffiths JR (1992) An assessment of 31P MRS as a method of measuring pH in rat tumours. NMR Biomed 5(6):351–359
Ha DH, Choi S, Oh JY, Yoon SK, Kang MJ, Kim KU (2013) Application of 31P MR spectroscopy to the brain tumors. Korean J Radiol 14(3):477–486. https://doi.org/10.3348/kjr.2013.14.3.477
Cichocka M, Kozub J, Urbanik A (2015) PH Measurements of the Brain Using Phosphorus Magnetic Resonance Spectroscopy (31PMRS) in Healthy Men – Comparison of Two Analysis Methods. Pol J Radiol. https://doi.org/10.12659/PJR.895178
Oberhaensli RD, Galloway GJ, Hilton-Jones D, Bore PJ, Styles P, Rajagopalan B, Taylor DJ, Radda GK (1987) The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy. Br J Radiol 60(712):367–373. https://doi.org/10.1259/0007-1285-60-712-367
Maintz D, Heindel W, Kugel H, Jaeger R, Lackner KJ (2002) Phosphorus-31 MR spectroscopy of normal adult human brain and brain tumours. NMR Biomed 15(1):18–27
Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891–899. https://doi.org/10.1038/nrc1478
Huber V, De Milito A, Harguindey S, Reshkin SJ, Wahl ML, Rauch C, Chiesi A, Pouyssegur J, Gatenby RA, Rivoltini L, Fais S (2010) Proton dynamics in cancer. J Transl Med 8:57. https://doi.org/10.1186/1479-5876-8-57
Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10(10):767–777. https://doi.org/10.1038/nrd3554
Webb BA, Chimenti M, Jacobson MP, Barber DL (2011) Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 11(9):671–677. https://doi.org/10.1038/nrc3110
Shrode LD, Tapper H, Grinstein S (1997) Role of intracellular pH in proliferation, transformation, and apoptosis. J Bioenerg Biomembr 29(4):393–399
Barar J, Omidi Y (2013) Dysregulated pH in tumor microenvironment checkmates Cancer therapy. Bioimpacts 3(4):149–162. https://doi.org/10.5681/bi.2013.036
Izumi H, Torigoe T, Ishiguchi H, Uramoto H, Yoshida Y, Tanabe M, Ise T, Murakami T, Yoshida T, Nomoto M, Kohno K (2003) Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev 29(6):541–549. https://doi.org/10.1016/s0305-7372(03)00106-3
Wood PJ, Sansom JM, Newell K, Tannock IF, Stratford IJ (1995) Reduction of tumour intracellular pH and enhancement of melphalan cytotoxicity by the ionophore Nigericin. Int J Cancer 60(2):264–268
Volk C, Kempski B, Kempski OS (1997) Inhibition of lactate export by quercetin acidifies rat glial cells in vitro. Neurosci Lett 223(2):121–124
Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, Choudhary B, Raghavan SC (2016) Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep 6:24049. https://doi.org/10.1038/srep24049
Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, Wang KY, Sasaguri Y, Nishizawa S, Kohno K (2011) Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 102(5):1007–1013. https://doi.org/10.1111/j.1349-7006.2011.01908.x
Perez-Escuredo J, Van Hee VF, Sboarina M, Falces J, Payen VL, Pellerin L, Sonveaux P (2016) Monocarboxylate transporters in the brain and in cancer. Biochim Biophys Acta 1863(10):2481–2497. https://doi.org/10.1016/j.bbamcr.2016.03.013
Kim JH, Kim SH, Alfieri AA, Young CW (1984) Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of HeLa cells. Cancer Res 44(1):102–106
McKay TB, Lyon D, Sarker-Nag A, Priyadarsini S, Asara JM, Karamichos D (2015) Quercetin attenuates lactate production and extracellular matrix secretion in keratoconus. Sci Rep 5:9003. https://doi.org/10.1038/srep09003
Sang DP, Li RJ, Lan Q (2014) Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27. Acta Pharmacol Sin 35(6):832–838. https://doi.org/10.1038/aps.2014.22
McVicar N, Li AX, Goncalves DF, Bellyou M, Meakin SO, Prado MA, Bartha R (2014) Quantitative tissue pH measurement during cerebral ischemia using amine and amide concentration-independent detection (AACID) with MRI. J Cereb Blood Flow Metab 34(4):690–698. https://doi.org/10.1038/jcbfm.2014.12
Zong X, Wang P, Kim SG, Jin T (2014) Sensitivity and source of amine-proton exchange and amide-proton transfer magnetic resonance imaging in cerebral ischemia. Magn Reson Med 71(1):118–132. https://doi.org/10.1002/mrm.24639
Zhou JY, Payen JF, Wilson DA, Traystman RJ, van Zijl PCM (2003) Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 9(8):1085–1090. https://doi.org/10.1038/nm907
Zhou JLB, Wilson DA, Laterra J, van Zijl PC (2003) Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 50:1120–1126. https://doi.org/10.1002/mrm.10651
Murray RK GD (2003) Membranes: structure & function. McGraw-Hill Companies, Inc:415–433
McVicar N, Li AX, Meakin SO, Bartha R (2015) Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine. NMR Biomed 28(5):566–575. https://doi.org/10.1002/nbm.3287
Marathe K, McVicar N, Li A, Bellyou M, Meakin S, Bartha R (2016) Topiramate induces acute intracellular acidification in glioblastoma. J Neuro-Oncol 130(3):465–472. https://doi.org/10.1007/s11060-016-2258-y
Albatany M, Li A, Meakin S, Bartha R (2017) Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 tesla. Journal of Neuro-oncology. https://doi.org/10.1007/s11060-017-2664-9
Reddy NS, Nirmala P, Chidambaram N, Kumar P, Nagar A (2012) Quercetin in dimethyl benzanthracene induced breast cancer in rats. Am J Pharmacol Toxicol 7(2):68–72
Li AX, Suchy M, Li C, Gati JS, Meakin S, Hudson RH, Menon RS, Bartha R (2011) In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T. Magn Reson Med 66(1):67–72. https://doi.org/10.1002/mrm.22772
Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC (2009) Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med 61(6):1441–1450. https://doi.org/10.1002/mrm.21873
Park HJ, Makepeace CM, Lyons JC, Song CW (1996) Effect of intracellular acidity and ionomycin on apoptosis in HL-60 cells. Eur J Cancer 32A(3):540–546
Park HJ, Lyons JC, Ohtsubo T, Song CW (1999) Acidic environment causes apoptosis by increasing caspase activity. Br J Cancer 80(12):1892–1897. https://doi.org/10.1038/sj.bjc.6690617
Jakubowicz-Gil J, Langner E, Wertel I, Piersiak T, Rzeski W (2010) Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. Chem Biol Interact 188(1):190–203. https://doi.org/10.1016/j.cbi.2010.07.015
Notman R, Noro M, O'Malley B, Anwar J (2006) Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes. J Am Chem Soc 128(43):13982–13983. https://doi.org/10.1021/ja063363t
Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Wang S, Yan K, Fu DX, Ford E, Tyler B, Blakeley J, Laterra J, van Zijl PC (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17(1):130–134. https://doi.org/10.1038/nm.2268
Acknowledgements
Funding for this study was provided by the Ontario Institute of Cancer Research (OICR) Smarter Imaging Program and the Canadian Institutes of Health Research (CIHR). MRI facilities were supported by Brain Canada and the Canada First Research Excellence Fund (BrainsCAN). Thanks to Misan University-Ministry of Higher Education and Scientific Research, Iraq.
Funding
This study was funded by the Ontario Institute of Cancer Research (OICR) Smarter Imaging Program (grant number 00807).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
All applicable national and institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
Rights and permissions
About this article
Cite this article
Albatany, M., Meakin, S. & Bartha, R. The Monocarboxylate transporter inhibitor Quercetin induces intracellular acidification in a mouse model of Glioblastoma Multiforme: in-vivo detection using magnetic resonance imaging. Invest New Drugs 37, 595–601 (2019). https://doi.org/10.1007/s10637-018-0644-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-018-0644-3